Cutaneous lesions from a blastic plasmacytoid dendritic cell neoplasm: a case report and literature review

被引:0
作者
Xin, Xing [1 ]
Tian, Ming [2 ]
Huang, Lifang [1 ]
Wang, Gaoxiang [1 ]
Cheng, Ling [1 ]
Liu, Zhaojun [1 ]
Dong, Peiyuan [1 ]
Meng, Fankai [1 ]
Sun, Hanying [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Hematol, Wuhan 430074, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Training, Wuhan 430074, Hubei, Peoples R China
关键词
Blastic plasmacytoid dendritic cell neoplasm (BPDCN); cutaneous lesions; mini-CHOP; ENDOPLASMIC-RETICULUM STRESS; SEQUENCING REVEALS; BONE-MARROW; INVOLVEMENT; MUTATIONS; APOPTOSIS; DIAGNOSIS; RECURRENT; LEUKEMIA; FEATURES;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive hematological malignancy that is derived from the precursors of plasmacytoid dendritic cells. Although BPDCN typically manifests in the skin, it can also evolve into a leukemic form or be complicated by acute myeloid leukemia, and some cases involve preceding myelodysplastic syndrome. We report the case of a 73-year-old Chinese man who presented with 2-year-old erythematous papules on his prothorax and back. Skin biopsy and immunohistochemistry revealed that the cells exhibited an immature blastic appearance (positive for CD4, CD123, and CD56, and negative for CD2, CD3, and CD20), which indicated a diagnosis of BPDCN. Due to his age, the patient was treated using methylprednisolone (20 mg/m2/day on days 1-7), which was followed by a mini-CHOP regimen (cyclophosphamide, doxorubicin, vincristine, and prednisone). We observed a significant treatment effect, and report this case to describe and discuss our experience with this successful treatment.
引用
收藏
页码:5017 / 5022
页数:6
相关论文
共 17 条
[1]   Is the BFM Regimen Feasible for the Treatment of Adult Acute Lymphoblastic Leukemia? A Retrospective Analysis of the Outcomes of BFM and Hyper-CVAD Chemotherapy in Two Centers [J].
Alacacioglu, Inci ;
Medeni, Serife S. ;
Ozsan, Guner H. ;
Payzin, Bahriye ;
Sevindik, O. Gokmen ;
Acar, Celal ;
Katgi, Abdullah ;
Ozdemirkan, Fusun ;
Piskin, Ozden ;
Ozcan, Mehmet A. ;
Undar, Bulent ;
Demirkan, Fatih .
CHEMOTHERAPY, 2014, 60 (04) :219-223
[2]   TET2 Mutations, Myelodysplastic Features, and A Distinct Immunoprofile Characterize Blastic Plasmacytoid Dendritic Cell Neoplasm in the Bone Marrow [J].
Alayed, Khaled ;
Patel, Keyur P. ;
Konoplev, Sergej ;
Singh, Rajesh R. ;
Routbort, Mark J. ;
Reddy, Neelima ;
Pemmaraju, Naveen ;
Zhang, Liping ;
Al Shaikh, Abdulaziz ;
Aladily, Tariq N. ;
Jain, Nitin ;
Luthra, Rajyalakshmi ;
Medeiros, L. Jeffrey ;
Khoury, Joseph D. .
AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (12) :1055-1061
[3]   Blastic Plasmacytoid Dendritic Cell Neoplasia (BPDC) in Elderly Patients: Results of a Treatment Algorithm Employing Allogeneic Stem Cell Transplantation with Moderately Reduced Conditioning Intensity [J].
Dietrich, Sascha ;
Andrulis, Mindaugas ;
Hegenbart, Ute ;
Schmitt, Thomas ;
Bellos, Frauke ;
Martens, Uwe M. ;
Meissner, Julia ;
Kraemer, Alwin ;
Ho, Anthony D. ;
Dreger, Peter .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (08) :1250-1254
[4]   Clinical and biologic features of CD4+CD56+ malignancies [J].
Feuillard, J ;
Jacob, MC ;
Valensi, F ;
Maynadié, M ;
Gressin, R ;
Chaperot, L ;
Arnoulet, C ;
Brignole-Baudouin, F ;
Drénou, B ;
Duchayne, E ;
Falkenrodt, A ;
Garand, R ;
Homolle, E ;
Husson, B ;
Kuhlein, E ;
Le Calvez, G ;
Sainty, D ;
Sotto, MF ;
Trimoreau, F ;
Béné, MC .
BLOOD, 2002, 99 (05) :1556-1563
[5]   Targeted diphtheria toxin to treat BPDCN [J].
FitzGerald, David J. .
BLOOD, 2014, 124 (03) :310-312
[6]   Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients [J].
Frankel, Arthur E. ;
Woo, Jung H. ;
Ahn, Chul ;
Pemmaraju, Naveen ;
Medeiros, Bruno C. ;
Carraway, Hetty E. ;
Frankfurt, Olga ;
Forman, Stephen J. ;
Yang, Xuezhong A. ;
Konopleva, Marina ;
Garnache-Ottou, Francine ;
Angelot-Delettre, Fanny ;
Brooks, Christopher ;
Szarek, Michael ;
Rowinsky, Eric .
BLOOD, 2014, 124 (03) :385-392
[7]   Blastic Plasmacytoid Dendritic Cell Neoplasm: Evolving Insights in an Aggressive Hematopoietic Malignancy With a Predilection of Skin Involvement [J].
Gera, Shweta ;
Dekmezian, Mhair S. ;
Duvic, Madeleine ;
Tschen, Jaime A. ;
Vega, Francisco ;
Cho-Vega, Jeong Hee .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2014, 36 (03) :244-251
[8]   Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm [J].
Hwang, Keumrock ;
Park, Chan-Jeoung ;
Jang, Seongsoo ;
Chi, Hyun-Sook ;
Huh, Joo-Ryung ;
Lee, Je Hwan ;
Suh, Cheolwon ;
Lee, Kyoo Hyung .
HISTOPATHOLOGY, 2013, 62 (05) :764-770
[9]   Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients [J].
Julia, F. ;
Petrella, T. ;
Beylot-Barry, M. ;
Bagot, M. ;
Lipsker, D. ;
Machet, L. ;
Joly, P. ;
Dereure, O. ;
Wetterwald, M. ;
d'Incan, M. ;
Grange, F. ;
Cornillon, J. ;
Tertian, G. ;
Maubec, E. ;
Saiag, P. ;
Barete, S. ;
Templier, I. ;
Aubin, F. ;
Dalle, S. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (03) :579-586
[10]   Endoplasmic reticulum stress-mediated aldosterone-induced apoptosis in vascular endothelial cells [J].
Lu, Jin-ping ;
Li, Xia ;
Jin, Ya-lei ;
Chen, Mei-xiang .
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2014, 34 (06) :821-824